Gordon MO - Search Results

1

Assessment of Cumulative Incidence and Severity of Primary Open-Angle Glaucoma Among Participants in the Ocular Hypertension Treatment Study After 20 Years of Follow-up.

Kass MA, Heuer DK, Higginbotham EJ, Parrish RK, Khanna CL, Brandt JD, Soltau JB, Johnson CA, Keltner JL, Huecker JB, Wilson BS, Liu L, Miller JP, Quigley HA, Gordon MO; Ocular Hypertension Study Group. Kass MA, et al. Among authors: gordon mo. JAMA Ophthalmol. 2021 Apr 15;139(5):1-9. doi: 10.1001/jamaophthalmol.2021.0341. Online ahead of print. JAMA Ophthalmol. 2021. PMID: 33856434 Free PMC article.

2

Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects.

Nesher R, Trick GL, Kass MA, Gordon MO. Nesher R, et al. Among authors: gordon mo. Doc Ophthalmol. 1990 Sep;75(2):101-9. doi: 10.1007/BF00146546. Doc Ophthalmol. 1990. PMID: 2276311 Clinical Trial.

3

Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial.

Kass MA, Gordon MO, Hoff MR, Parkinson JM, Kolker AE, Hart WM Jr, Becker B. Kass MA, et al. Among authors: gordon mo. Arch Ophthalmol. 1989 Nov;107(11):1590-8. doi: 10.1001/archopht.1989.01070020668025. Arch Ophthalmol. 1989. PMID: 2818278 Clinical Trial.

4

Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma.

Lewis JM, Priddy T, Judd J, Gordon MO, Kass MA, Kolker AE, Becker B. Lewis JM, et al. Among authors: gordon mo. Am J Ophthalmol. 1988 Nov 15;106(5):607-12. doi: 10.1016/0002-9394(88)90595-8. Am J Ophthalmol. 1988. PMID: 3189477

5

Compliance with topical pilocarpine treatment.

Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Kass MA, et al. Am J Ophthalmol. 1986 May 15;101(5):515-23. doi: 10.1016/0002-9394(86)90939-6. Am J Ophthalmol. 1986. PMID: 3706455

6

Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy?

Kass MA, Gordon M, Meltzer DW. Kass MA, et al. Am J Ophthalmol. 1986 May 15;101(5):524-30. doi: 10.1016/0002-9394(86)90940-2. Am J Ophthalmol. 1986. PMID: 3706456

7

Compliance with topical timolol treatment.

Kass MA, Gordon M, Morley RE Jr, Meltzer DW, Goldberg JJ. Kass MA, et al. Am J Ophthalmol. 1987 Feb 15;103(2):188-93. doi: 10.1016/s0002-9394(14)74225-4. Am J Ophthalmol. 1987. PMID: 3812621

8

A dose-response study of the effect of levobunolol on ocular hypertension.

Partamian LG, Kass MA, Gordon M. Partamian LG, et al. Am J Ophthalmol. 1983 Feb;95(2):229-32. doi: 10.1016/0002-9394(83)90018-1. Am J Ophthalmol. 1983. PMID: 6337497 Clinical Trial.

9

A miniature compliance monitor for eyedrop medication.

Kass MA, Meltzer DW, Gordon M. Kass MA, et al. Arch Ophthalmol. 1984 Oct;102(10):1550-4. doi: 10.1001/archopht.1984.01040031266033. Arch Ophthalmol. 1984. PMID: 6385936 Clinical Trial.

10

Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension.

Kass MA, Hart WM Jr, Gordon M, Miller JP. Kass MA, et al. Surv Ophthalmol. 1980 Nov-Dec;25(3):155-62. doi: 10.1016/0039-6257(80)90092-2. Surv Ophthalmol. 1980. PMID: 7008228 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page